New prophylactic immunomodulation for upcoming 4D-310 trials presented
Feb. 10, 2025
Fabry disease is an X-linked lysosomal storage disorder caused by a deficiency of the enzyme α-galactosidase A (GLA), which leads to complex multisystemic involvement, with the majority of patients developing hypertrophic cardiomyopathy.